| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/17/2007 | US7205099 Applying potential then measuring electrical signals; drug screening |
| 04/17/2007 | US7204990 Attenuation of cytomegalovirus virulence |
| 04/17/2007 | US7204989 For diagnosis of Hepatitis E virus, use in a vaccine for the prevention of HEV in humans |
| 04/17/2007 | US7204981 Methods of treating diseases with activated protein C |
| 04/17/2007 | US7204980 Methods for inhibiting viral replication in vivo |
| 04/17/2007 | CA2310510C Method for identifying and inhibiting functional nucleic acid molecules in cells |
| 04/17/2007 | CA2287902C Isolated nucleic acid molecules encoding ssx family members and uses thereof |
| 04/17/2007 | CA2202477C Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/17/2007 | CA2199213C Amplifying and detecting target nucleic acids using a post amplification incubation step |
| 04/17/2007 | CA2184175C Isolated, tyrosinase derived peptides and uses thereof |
| 04/17/2007 | CA2175478C Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease |
| 04/17/2007 | CA2149420C Microporous macrocapsules |
| 04/17/2007 | CA2127450C Transgenic animal models for alzheimer's disease |
| 04/17/2007 | CA2073298C Process for controlling contamination of nucleic acid amplification reactions |
| 04/14/2007 | CA2564064A1 Genetic variations associated with psychiatric disorders |
| 04/14/2007 | CA2523399A1 Genetic variations associated with psychiatric disorders |
| 04/13/2007 | CA2564464A1 Multiplexed solid-phase nucleic acid amplification assay |
| 04/12/2007 | WO2007041692A2 Microfluidic detection of analytes |
| 04/12/2007 | WO2007041680A2 The genetic risk assessment in heart failure: impact of genetic variation of beta 1 adrenergic receptor gly389arg polymorphism |
| 04/12/2007 | WO2007041676A2 The genetic risk assessment in heart failure: impact of genetic variation of aldosterone synthase promoter polymorphism |
| 04/12/2007 | WO2007041621A2 Hybridization assisted nanopore sequencing |
| 04/12/2007 | WO2007041596A2 Compositions and methods for the treatment of cancer |
| 04/12/2007 | WO2007041511A2 Hematopoietic progenitor kinase 1 for modulation of an immune response |
| 04/12/2007 | WO2007041452A2 Methods for preparation of live body tissue for examination |
| 04/12/2007 | WO2007041359A2 Compositions and methods relating to cornelia de lange syndrome |
| 04/12/2007 | WO2007041342A2 Labeled nucleotide analogs and uses therefor |
| 04/12/2007 | WO2007041340A2 Microfluidic cells with parallel arrays of individual dna molecules |
| 04/12/2007 | WO2007041283A2 Maternal chelation for embryo, fetal, and infant benefit |
| 04/12/2007 | WO2007041268A2 Transporter-targeted methods of diagnosis and treatment |
| 04/12/2007 | WO2007041238A2 Methods of identification and use of gene signatures |
| 04/12/2007 | WO2007041219A2 Compositions and methods for il13 biomarkers |
| 04/12/2007 | WO2007041201A2 Compositions, methods, and kits for amplifying nucleic acids |
| 04/12/2007 | WO2007041138A2 Process and apparatus for measuring binding events on a microarray of electrodes |
| 04/12/2007 | WO2007041067A2 Methods and compositions for kir genotyping |
| 04/12/2007 | WO2007040944A1 Membrane system for blood coagulation testing |
| 04/12/2007 | WO2007040925A1 Membrane system for blood coagulation testing |
| 04/12/2007 | WO2007040913A1 Gated voltammetry |
| 04/12/2007 | WO2007040658A2 Ligand arrays having controlled feature size, and methods of making and using the same |
| 04/12/2007 | WO2007040654A2 Methods to identify antimicrobial compounds that interrupt ribosome biogenesis |
| 04/12/2007 | WO2007040592A1 Making nucleic acid sequences in parallel and use |
| 04/12/2007 | WO2007040385A1 Control of preservation by biomarkers |
| 04/12/2007 | WO2007040287A1 Dna collection sticker and method for isolating dna from the sticker |
| 04/12/2007 | WO2007040123A1 Method for detection of human precursor t cell and precursor b cell |
| 04/12/2007 | WO2007040117A1 Method of simultaneously measuring a plural number of cell responses |
| 04/12/2007 | WO2007040003A1 Method of observing dynamic state of intracellular structure and observation apparatus |
| 04/12/2007 | WO2007039986A1 Method of obtaining pancreatic endocrine cells from adipose tissue-origin cells |
| 04/12/2007 | WO2007039963A1 Brain tumor marker for prediction of prognosis of patient with brain tumor and use thereof |
| 04/12/2007 | WO2007039906A2 Method for analyzing gene expression data |
| 04/12/2007 | WO2007039724A1 Snps in the apob gene and susceptibility to increased levels of alat following ximelagatran administration |
| 04/12/2007 | WO2007039722A1 POLYMORPHISMS IN PONl ARE ASSOCIATED WITH ELEVATED ALANINE AMINOTRANSFERASE LEVELS AFTER XIMELAGATRAN OR TACRINE ADMINISTRATION |
| 04/12/2007 | WO2007039721A1 ASSOCIATION BETWEEN HLA-DRBl* 07 ALLELE AND SUSCEPTIBILY TO INCREASED LEVELS OF ALAT FOLLOWING XIMELAGATRAN ADMINISTRATION |
| 04/12/2007 | WO2007039718A1 Polymorphisms in mgst3 are associated with elevated alat levels after ximelagatran treatment |
| 04/12/2007 | WO2007039705A1 Method to predict or monitor the response of a patient to an erbb receptor drug |
| 04/12/2007 | WO2007039319A2 Dna microarray for rapid identification of candida albicans in blood cultures |
| 04/12/2007 | WO2007039301A2 Non-fluorescent energy transfer |
| 04/12/2007 | WO2007039268A1 Methods for regulating metabolism and diagnosing disease |
| 04/12/2007 | WO2007039255A1 Tumor angiogenesis associated genes and a method for their identification |
| 04/12/2007 | WO2007039234A2 Methods and nucleic acids for the analysis of gene expression associated with tissue classification |
| 04/12/2007 | WO2007039232A2 Means and methods for diagnosing atgl related disorders |
| 04/12/2007 | WO2007039182A1 oriC SPECIFIC NUCLEIC ACID SEQUENCES AND USE THEREOF |
| 04/12/2007 | WO2007039147A1 Methods of using il-21 |
| 04/12/2007 | WO2007039128A1 Markers for the prediction of outcome of anthracycline treatment |
| 04/12/2007 | WO2007039101A1 Method for the quantification of nucleic acids, in particular bisulfite treated dna |
| 04/12/2007 | WO2007039075A2 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 04/12/2007 | WO2007038876A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | WO2007038869A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | WO2007024840A3 Method of quantitating nucleic acids by flow cytometry microparticle-based array |
| 04/12/2007 | WO2007019595A3 Method for the detection of an external administration of human growth hormone (hgh) |
| 04/12/2007 | WO2007018760A3 Preparation of plastic supports for biochips |
| 04/12/2007 | WO2007014338A8 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
| 04/12/2007 | WO2007011392A9 Crystal structure of domain 111 of west nile virus envelope protein-fab fragment of neutralizing antibody complex |
| 04/12/2007 | WO2007010263A3 Methods for sequencing a polynucleotide template |
| 04/12/2007 | WO2007006520A3 Method for the identification of sulfo-oxidizing bacteria and for the monitoring of elemental sulfur in the environment |
| 04/12/2007 | WO2006135775A3 Rapid saccharide biomarker assay |
| 04/12/2007 | WO2006133266A9 Methods for determining resistance or susceptibility to hiv entry inhibitors |
| 04/12/2007 | WO2006128740A3 Anti-vascular methods and therapies employing lysyl oxidase inhibitors |
| 04/12/2007 | WO2006128277A3 Method for detecting flavour compounds in fermented products using enzymes |
| 04/12/2007 | WO2006128010A3 Quantification of nucleic acids and proteins using oligonucleotide mass tags |
| 04/12/2007 | WO2006121869A3 Compositions and methods for treating mood and anxiety disorders |
| 04/12/2007 | WO2006116699A3 Method and system for absolute platelet percent aggregation determination |
| 04/12/2007 | WO2006116083A3 The 1, 5-anhydroglucitol (1, 5-ag) assay and a1c/1. 5-ag assay combination for measuring blood glucose excursions in general and postprandial hyperglycemia in diabetic patients |
| 04/12/2007 | WO2006110599A3 Cacna1e in cancer diagnosis, detection and treatment |
| 04/12/2007 | WO2006105537A3 Human niemann pick c1-like 1 gene (npc1l1) polymorphisms and methods of use thereof |
| 04/12/2007 | WO2006097463A3 Compositions and methods for treating and diagnosing inflammatory disorders |
| 04/12/2007 | WO2006090400A3 Method and structure for bio-mediated, self-assembled metal-filled nanotube devices and interconnects |
| 04/12/2007 | WO2006089209A3 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 04/12/2007 | WO2006083671B1 Bacterial glycolipid activation of cd1d-restricted nkt cells |
| 04/12/2007 | WO2006074108A3 Compositions and methods for modulating gene expression using self-protected oligonucleotides |
| 04/12/2007 | WO2006071903A3 Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions |
| 04/12/2007 | WO2006053246A3 A new sos 1 gene from halophila that confers salt tolerance |
| 04/12/2007 | WO2006050275A3 Rapid species-specific detection of pathogens |
| 04/12/2007 | WO2006048263A3 Gene expression profiling in acute promyelocytic leukemia |
| 04/12/2007 | WO2006044486A3 Methods and compositions for the utilization and targeting of osteomimicry |
| 04/12/2007 | WO2006041938A3 Micropatterned plate with micro-pallets for addressable biochemical analysis |
| 04/12/2007 | WO2006017473A3 Automated analysis of multiplexed probe-traget interaction patterns: pattern matching and allele identification |
| 04/12/2007 | WO2005121332A3 Truncated st6galnaci polypeptides and nucleic acids |
| 04/12/2007 | WO2005113831A3 Biomarkers for multiple sclerosis and methods of use thereof |
| 04/12/2007 | WO2005107796A3 Cellular permissivity factor for viruses, and uses thereof |
| 04/12/2007 | WO2005106047A3 Detection of molecular interactions using colloid dispersion |
| 04/12/2007 | WO2005086679A3 Methods and compositions for assessing nucleic acids and alleles |